Literature DB >> 5037388

Harmine tremor after brain monoamine oxidase inhibition in the mouse.

G H Coates, B Cox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5037388     DOI: 10.1016/0014-2999(72)90255-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  4 in total

1.  Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.

Authors:  Natividad Pozo; Cristina Zahonero; Paloma Fernández; Jose M Liñares; Angel Ayuso; Masatoshi Hagiwara; Angel Pérez; Jose R Ricoy; Aurelio Hernández-Laín; Juan M Sepúlveda; Pilar Sánchez-Gómez
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

2.  The influence of dietaryβ-carboline alkaloids on growth rate, food consumption, and food utilization of larvae ofSpodoptera exigua (Hubner).

Authors:  J C Cavin; E Rodriguez
Journal:  J Chem Ecol       Date:  1988-02       Impact factor: 2.626

3.  Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.

Authors:  Michael Tarpley; Helen O Oladapo; Dillon Strepay; Thomas B Caligan; Lhoucine Chdid; Hassan Shehata; Jose R Roques; Rhashad Thomas; Christopher P Laudeman; Rob U Onyenwoke; David B Darr; Kevin P Williams
Journal:  Eur J Pharm Sci       Date:  2021-03-27       Impact factor: 5.112

4.  Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.

Authors:  Katharina E Meijboom; Viola Volpato; Jimena Monzón-Sandoval; Joseph M Hoolachan; Suzan M Hammond; Frank Abendroth; Olivier G de Jong; Gareth Hazell; Nina Ahlskog; Matthew Ja Wood; Caleb Webber; Melissa Bowerman
Journal:  JCI Insight       Date:  2021-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.